Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AquaBounty Technologies, Inc. (AQB : NSDQ)
 
 • Company Description   
AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States.

Number of Employees: 4

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.79 Daily Weekly Monthly
20 Day Moving Average: 223,212 shares
Shares Outstanding: 3.87 (millions)
Market Capitalization: $3.04 (millions)
Beta: 1.18
52 Week High: $1.94
52 Week Low: $0.47
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.76% -9.29%
12 Week 20.89% 1.69%
Year To Date 25.45% 17.48%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
233 AYER ROAD SUITE 4
-
HARVARD,MA 01451
USA		 ph: 978-648-6000
fax: -		 investors@aquabounty.com http://www.aquabounty.com
 
 • General Corporate Information   
Officers
David A. Frank - Interim Chief Executive Officer; Chief Financial O
Sylvia A. Wulf - Board Chairman
Ricardo Alvarez - Lead Independent Director
Erin Sharp - Director
Gail Sharps Myers - Director

Peer Information
AquaBounty Technologies, Inc. (CORR.)
AquaBounty Technologies, Inc. (RSPI)
AquaBounty Technologies, Inc. (CGXP)
AquaBounty Technologies, Inc. (BGEN)
AquaBounty Technologies, Inc. (GTBP)
AquaBounty Technologies, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 03842K309
SIC: 900
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 3.87
Most Recent Split Date: 10.00 (0.05:1)
Beta: 1.18
Market Capitalization: $3.04 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.18
Price/Cash Flow: -
Price / Sales: 2.42
EPS Growth
vs. Year Ago Period: 110.46%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -93.45%
vs. Previous Quarter: -73.33%
ROE
06/30/25 - -
03/31/25 - -111.70
12/31/24 - -77.69
ROA
06/30/25 - -
03/31/25 - -85.47
12/31/24 - -63.64
Current Ratio
06/30/25 - -
03/31/25 - 0.54
12/31/24 - 0.70
Quick Ratio
06/30/25 - -
03/31/25 - 0.54
12/31/24 - 0.70
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - 4.39
12/31/24 - 4.10
Inventory Turnover
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.13
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 11.19
 

Powered by Zacks Investment Research ©